| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64 |
| filingDate |
2013-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2018-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-104640873-B |
| titleOfInvention |
Anticancer and anti-fat ring-type peptide agent |
| abstract |
It is used for anticancer or the anti-fat compound with structure formula (I) or structure formula (II) the present invention relates to a kind of： |
| priorityDate |
2012-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |